Company profile for Angelini Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Angelini Fine Chemicals is Angelini Pharma S.p.A. Business Unit fully dedicated to the development and manufacture of small molecules API for the global Pharmaceutical market. Angelini Fine Chemicals is a major EU CDMO serving the pharmaceutical industry. Equipped with state-of-the-art R&D labs and over 70.000 m2 cGMP manufacturing facility, Angelini Fine Chemicals is well positioned for the development and manufacturing of t...
Angelini Fine Chemicals is Angelini Pharma S.p.A. Business Unit fully dedicated to the development and manufacture of small molecules API for the global Pharmaceutical market. Angelini Fine Chemicals is a major EU CDMO serving the pharmaceutical industry. Equipped with state-of-the-art R&D labs and over 70.000 m2 cGMP manufacturing facility, Angelini Fine Chemicals is well positioned for the development and manufacturing of target molecules of relevance to the pharmaceutical market. We have a wide reaction portfolio and niche chemical technologies (such as Flow Chemistry & HPAPI) ensuring to resolve complex process chemistry & scale up issue

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Via Guardapasso, 1 - 04011 Aprilia (LT) Italy
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

SCOPE Summit

SCOPE Summit

Not Confirmed

envelop Contact Supplier

SCOPE Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-01-21/angelini-pharma-announces-appointment-of-sergio-marullo-di-condojanni-as-new-ceo

PHARMIWEB
21 Jan 2026

https://www.fiercebiotech.com/biotech/european-union-teams-angelini-funnel-eu150m-european-health-startups

FIERCE BIOTECH
01 Dec 2025

https://www.pharmiweb.com/press-release/2025-11-25/angelini-pharma-uk-i-limited-has-breached-the-abpi-code-of-practice-for-the-pharmaceutical-industry-and-brought-discredit-upon-and-reduced-confidence

PHARMIWEB
25 Nov 2025

https://www.fiercepharma.com/marketing/angelini-faces-watchdogs-wrath-after-speaker-blasts-stupid-ema

FIERCE PHARMA
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187094/0/en/Angelini-Ventures-to-support-Singapore-biotech-ecosystem-development-with-first-Asia-office.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/09/22/3154092/0/en/Angelini-Pharma-Signs-Exclusive-Option-Agreement-With-Sovargen-To-License-Global-Development-and-Commercialization-Rights-For-Innovative-Brain-Health-Asset.html

GLOBENEWSWIRE
22 Sep 2025

01

Trazodone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Trazodone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

02

Acamprosate Calcium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Acamprosate Calcium

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

03

Benzydamine Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Benzydamine Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Dapiprazole Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Dapiprazole Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

05

Metaxalone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Metaxalone

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Trazodone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Trazodone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Etoperidone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Etoperidone Hydrochloride

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Lonidamine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Lonidamine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Mirtazapine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

Mirtazapine

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

FACILITIES IN APRILIA, ITALY

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

SCOPE Summit
Not Confirmed
arrow

FACILITIES IN APRILIA, ITALY

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
SCOPE Summit
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Radiprodil is a small molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of GRIN-related Neurodevelopmental Disorder.


Lead Product(s): Radiprodil

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Recipient: GRIN Therapeutics

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 04, 2025

blank

01

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Radiprodil is a small molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of GRIN-related Neurodevelopmental Disorder.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

November 04, 2025

blank

Details:

Benzydamine HCl is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Anemia, Sickle Cell.


Lead Product(s): Benzydamine Hydrochloride

Therapeutic Area: Genetic Disease Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Cross Research S.A.

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 30, 2025

blank

02

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Benzydamine HCl is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of Anemia, Sickle Cell.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 30, 2025

blank

Details:

Angelini Pharma and Sovargen will collaboratively lead the pre-clinical development efforts for SVG105, a potentially first-in-class anti-sense oligonucleotide technology to target mTOR pathways.


Lead Product(s): SVG105

Therapeutic Area: Neurology Brand Name: SVG105

Study Phase: PreclinicalProduct Type: Oligonucleotide

Recipient: SoVarGen

Deal Size: $550.0 million Upfront Cash: Undisclosed

Deal Type: Agreement September 22, 2025

blank

03

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Angelini Pharma and Sovargen will collaboratively lead the pre-clinical development efforts for SVG105, a potentially first-in-class anti-sense oligonucleotide technology to target mTOR pathways.

Product Name : SVG105

Product Type : Oligonucleotide

Upfront Cash : Undisclosed

September 22, 2025

blank

Details:

Angelini Pharma will receive exclusive rights to commercialize radiprodil, currently being studied in multiple rare genetic epilepsies and neurodevelopmental disorders, outside north america.


Lead Product(s): Radiprodil

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Recipient: GRIN Therapeutics

Deal Size: $570.0 million Upfront Cash: $50.0 million

Deal Type: Collaboration May 27, 2025

blank

04

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Angelini Pharma will receive exclusive rights to commercialize radiprodil, currently being studied in multiple rare genetic epilepsies and neurodevelopmental disorders, outside north america.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : $50.0 million

May 27, 2025

blank

Details:

Trazodone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Trazodone Hydrochloride

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: SocraTec R&D GmbH

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 14, 2025

blank

05

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Trazodone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 14, 2025

blank

Details:

Under the agreement, Angelini Pharma will lead all the development efforts for CV-01, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases.


Lead Product(s): CV-01

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Recipient: Cureverse

Deal Size: $360.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement October 21, 2024

blank

06

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Under the agreement, Angelini Pharma will lead all the development efforts for CV-01, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Undisclosed

October 21, 2024

blank

Details:

Through the agreement, Angelini Pharma will focus on commercializing Mesulid (nimesulide) in Europe. It is indicated for treating patients suffering from acute pain.


Lead Product(s): Nimesulide

Therapeutic Area: Neurology Brand Name: Mesulid

Study Phase: Approved FDFProduct Type: Miscellaneous

Recipient: Helsinn Advanced Synthesis

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement May 24, 2024

blank

07

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Through the agreement, Angelini Pharma will focus on commercializing Mesulid (nimesulide) in Europe. It is indicated for treating patients suffering from acute pain.

Product Name : Mesulid

Product Type : Miscellaneous

Upfront Cash : Undisclosed

May 24, 2024

blank

Details:

Acetaminophen is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Paracetamol

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Miscellaneous

Sponsor: Cross Research S.A.

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 10, 2024

blank

08

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Acetaminophen is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 10, 2024

blank

Details:

Ontozry (cenobamate), is an antiseizure medication (ASM) for adults with partial-onset (focal) seizures, is now approved as oral suspension or can be administered via a nasogastric tube.


Lead Product(s): Cenobamate

Therapeutic Area: Neurology Brand Name: Ontozry

Study Phase: Approved FDFProduct Type: Controlled Substance

Sponsor: SK Biopharmaceuticals

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 16, 2023

blank

09

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : Ontozry (cenobamate), is an antiseizure medication (ASM) for adults with partial-onset (focal) seizures, is now approved as oral suspension or can be administered via a nasogastric tube.

Product Name : Ontozry

Product Type : Controlled Substance

Upfront Cash : Inapplicable

May 16, 2023

blank

Details:

The collaboration combines Angelini Pharma’s expertise in neurological diseases with JCR Pharmaceuticals’ J-Brain Cargo®, blood-brain barrier penetrating technology to develop highly innovative brain-penetrant biologic therapeutics in epilepsy.


Lead Product(s): Undisclosed

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: DiscoveryProduct Type: Undisclosed

Recipient: JCR Pharmaceuticals

Deal Size: $505.5 million Upfront Cash: Undisclosed

Deal Type: Collaboration May 11, 2023

blank

10

SCOPE Summit
Not Confirmed
SCOPE Summit
Not Confirmed

Details : The collaboration combines Angelini Pharma’s expertise in neurological diseases with JCR Pharmaceuticals’ J-Brain Cargo®, blood-brain barrier penetrating technology to develop highly innovative brain-penetrant biologic therapeutics in epilepsy.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Undisclosed

May 11, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Brand Name : Tachipirina Flashtab

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina Flashtab

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachipirina Flashtab

Dosage Strength : 16 Cpr 500 Mg ...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

Brand Name : Tachipirina Flashtab

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina Flashtab

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachipirina Flashtab

Dosage Strength : 12 Cpr Dispers 250 Mg ...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

Brand Name : Tachipirina

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachipirina

Dosage Strength : 12 Cpr Eff 1,000 Mg ...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

Brand Name : Tachipirina

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachipirina

Dosage Strength : 16 Cpr 1000 Mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Brand Name : Tachicaf

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachicaf

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachicaf

Dosage Strength : 16 Bust Grat Eff 1 G/1...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

Brand Name : Tachidol

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachidol

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form : Paracetamol+Codeine 500+...

Brand Name : Tachidol

Dosage Strength : 16 cpr riv div 500 mg ...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Brand Name : Tachidol

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachidol

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachidol

Dosage Strength : The Scir 120 Ml ...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Brand Name : Tachidol

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachidol

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Tachidol

Dosage Strength : To 10 Bust Grat Eff 50...

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

Brand Name : Bel Labial

SCOPE Summit
Not Confirmed
arrow

Brand Name : Bel Labial

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form : Cream

Brand Name : Bel Labial

Dosage Strength : 50MG

Packaging :

Approval Date : 27-07-2001

Application Number : 64138

Regulatory Info : Cancelled

Registration Country : Spain

blank

10

Brand Name : Vitamin C

SCOPE Summit
Not Confirmed
arrow

Brand Name : Vitamin C

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Brand Name : Vitamin C

Dosage Strength : 10 Vials Im Ev 500 Mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Brand Name : OLEPTRO

SCOPE Summit
Not Confirmed
arrow

Brand Name : OLEPTRO

SCOPE Summit
Not Confirmed
arrow

Angelini Pharma

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Proprietary Name : OLEPTRO

Dosage Strength : 150MG **Federal Register...

Approval Date : 2010-02-02

Application Number : 22411

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

02

Brand Name : OLEPTRO

SCOPE Summit
Not Confirmed
arrow

Brand Name : OLEPTRO

SCOPE Summit
Not Confirmed
arrow

Angelini Pharma

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Proprietary Name : OLEPTRO

Dosage Strength : 300MG **Federal Register...

Approval Date : 2010-02-02

Application Number : 22411

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

Europe

read-more
read-more

01

Brand Name : Tachipirina Flashtab

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina Flashtab

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : 16 Cpr 500 Mg ...

Packaging :

Brand Name : Tachipirina Flashtab

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

Brand Name : Tachipirina Flashtab

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina Flashtab

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : 12 Cpr Dispers 250 Mg ...

Packaging :

Brand Name : Tachipirina Flashtab

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

Brand Name : Tachipirina

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : 12 Cpr Eff 1,000 Mg ...

Packaging :

Brand Name : Tachipirina

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

Brand Name : Tachipirina

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachipirina

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : 16 Cpr 1000 Mg

Packaging :

Brand Name : Tachipirina

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

Brand Name : Tachicaf

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachicaf

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : 16 Bust Grat Eff 1 G/130 Mg

Packaging :

Brand Name : Tachicaf

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

Brand Name : Tachidol

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachidol

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form : Paracetamol+Codeine 500+30Mg 1...

Dosage Strength : 16 cpr riv div 500 mg + 30 ...

Packaging :

Brand Name : Tachidol

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

Brand Name : Tachidol

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachidol

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : The Scir 120 Ml ...

Packaging :

Brand Name : Tachidol

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

Brand Name : Tachidol

SCOPE Summit
Not Confirmed
arrow

Brand Name : Tachidol

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : To 10 Bust Grat Eff 500 Mg ...

Packaging :

Brand Name : Tachidol

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

Brand Name : Bel Labial

SCOPE Summit
Not Confirmed
arrow

Brand Name : Bel Labial

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form : Cream

Dosage Strength : 50MG

Packaging :

Brand Name : Bel Labial

Approval Date : 27-07-2001

Application Number : 64138

Regulatory Info : Cancelled

Registration Country : Spain

blank

10

Brand Name : Vitamin C

SCOPE Summit
Not Confirmed
arrow

Brand Name : Vitamin C

arrow
SCOPE Summit
Not Confirmed

Angelini Pharma

Dosage Form :

Dosage Strength : 10 Vials Im Ev 500 Mg

Packaging :

Brand Name : Vitamin C

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Services

Upload your portfolio for free, ask us

Analytical

Click here to discover the service providers for Analytical

API Manufacturing

Click here to discover the service providers for API Manufacturing

High Potency APIs (HPAPIs)

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API & Drug Product Development

Click here to discover the service providers for API & Drug Product Development

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Angelini Pharma and get a quotation

Angelini Pharma is a supplier offers 17 products (APIs, Excipients or Intermediates).

Find a price of Trazodone Hydrochloride bulk with DMF, CEP offered by Angelini Pharma

Find a price of Acamprosate Calcium bulk with DMF offered by Angelini Pharma

Find a price of Benzydamine Hydrochloride bulk with CEP offered by Angelini Pharma

Find a price of Dapiprazole Hydrochloride bulk with DMF offered by Angelini Pharma

Find a price of Metaxalone bulk with DMF offered by Angelini Pharma

Find a price of Trazodone Hydrochloride bulk with CEP offered by Angelini Pharma

Find a price of Etoperidone Hydrochloride bulk offered by Angelini Pharma

Find a price of Lonidamine bulk offered by Angelini Pharma

Find a price of Mirtazapine bulk offered by Angelini Pharma

Find a price of FACILITIES IN APRILIA, ITALY bulk offered by Angelini Pharma

Find a price of FACILITIES AND OPERATING PROCEDURES IN ANCONA, ITALY bulk offered by Angelini Pharma

Find a price of MFG. SITE AND FACILITIES LOCATED IN APRILIA (LT) ITALY bulk offered by Angelini Pharma

Find a price of Bendazac bulk offered by Angelini Pharma

Find a price of Ibopamine bulk offered by Angelini Pharma

Find a price of Ospemifene bulk offered by Angelini Pharma

Find a price of Oxolamine Citrate bulk offered by Angelini Pharma

Find a price of Oxolamine Phosphate bulk offered by Angelini Pharma

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty